Share Price and Basic Stock Data
Last Updated: December 19, 2025, 10:32 pm
| PEG Ratio | 0.29 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Bhaskar Agrochemicals Ltd operates in the agrochemicals sector, focusing on the production and distribution of pesticides. As of the latest financials, the company’s market capitalization stood at ₹67.2 Cr, with a share price of ₹129. Over the past few years, revenue has shown notable fluctuations, with sales for FY 2025 recording ₹91 Cr, an increase from ₹67 Cr in FY 2024, indicating a growth trajectory. However, quarterly sales reveal a more volatile pattern, with a significant dip in Q1 FY 2025 at ₹9.48 Cr, followed by a rebound to ₹22.31 Cr in Q4 FY 2025. The company’s ability to manage sales effectively during seasonal demand cycles will be crucial for sustaining growth in an industry where timing can significantly impact performance. This variability in revenue, coupled with an overall TTM sales figure of ₹102 Cr, underscores the challenges faced in maintaining consistent performance in a competitive landscape.
Profitability and Efficiency Metrics
Profitability metrics for Bhaskar Agrochemicals present a mixed picture. The company’s operating profit margin (OPM) was reported at 10.09% for FY 2025, reflecting an improvement from 9% in FY 2024. This upward trend in profitability is a positive sign, albeit from a low base. The net profit of ₹4 Cr for FY 2025, which translates to an earnings per share (EPS) of ₹7.48, shows a recovery from previous years, particularly after a challenging FY 2023 where net profit was just ₹0.44 Cr. However, the operating profit has demonstrated variability, with negative figures in earlier quarters. The interest coverage ratio, which stood at 4.56x, suggests that the company is comfortably covering its debt obligations, but the cash conversion cycle of 155 days indicates potential inefficiencies in working capital management, which could hinder overall profitability if not addressed.
Balance Sheet Strength and Financial Ratios
Examining Bhaskar Agrochemicals’ balance sheet reveals both strengths and vulnerabilities. The company reported total borrowings of ₹20 Cr against reserves of ₹16 Cr, indicating a reliance on debt financing that could be a concern in times of economic downturn. The debt-to-equity ratio of 1.07x highlights a moderately leveraged position, which may pose risks if cash flows do not stabilize. However, the return on equity (ROE) at 21.95% is impressive, suggesting that the company is generating substantial returns on shareholders’ funds. The current ratio of 1.20x indicates a sound liquidity position, allowing it to meet short-term obligations. Furthermore, the price-to-book value ratio of 2.29x suggests that the stock may be trading at a premium, which could be justified by its strong ROE but may also imply that investors are factoring in future growth potentials.
Shareholding Pattern and Investor Confidence
Bhaskar Agrochemicals has a stable shareholding pattern, with promoters holding 62.28% of the company as of June 2025. This level of promoter holding can instill confidence among retail investors, as it indicates a strong commitment from the founders. The public shareholding stands at 37.72%, with a notable increase in the number of shareholders, which rose to 4,552 in June 2025 from 3,871 in December 2022. This growing interest from the public can be interpreted as a positive sign of increasing investor confidence in the company’s prospects. However, the absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) may suggest a lack of institutional backing, which could be a red flag for some investors looking for stability and long-term growth.
Outlook, Risks, and Final Insight
Looking ahead, Bhaskar Agrochemicals faces a dual-edged sword of opportunities and risks. On one hand, the agrochemical sector is poised for growth, driven by increasing agricultural demands and a push for higher productivity. The company’s improving profitability metrics and robust ROE are indicative of its potential to capitalize on this growth. On the other hand, the volatility in quarterly sales, high working capital days, and reliance on debt could pose significant risks. Investors should be cautious about the company’s ability to maintain steady cash flows and manage its debt effectively. In this evolving landscape, potential investors might consider the stock as a speculative play, weighing the promising growth against the inherent risks of operational inefficiencies and market dependence. As always, due diligence in monitoring the company’s performance and sector trends will be essential for making informed investment decisions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Epigral Ltd | 5,993 Cr. | 1,389 | 2,114/1,374 | 14.9 | 487 | 0.43 % | 24.9 % | 22.3 % | 10.0 |
| Dharmaj Crop Guard Ltd | 824 Cr. | 244 | 391/165 | 16.9 | 131 | 0.00 % | 12.0 % | 9.28 % | 10.0 |
| Bhaskar Agrochemicals Ltd | 63.8 Cr. | 122 | 149/56.6 | 11.4 | 40.0 | 0.00 % | 21.3 % | 24.7 % | 10.0 |
| Bhagiradha Chemicals & Industries Ltd | 2,976 Cr. | 230 | 331/222 | 112 | 54.9 | 0.07 % | 7.44 % | 4.91 % | 1.00 |
| Best Agrolife Ltd | 906 Cr. | 383 | 650/244 | 70.8 | 342 | 0.78 % | 12.9 % | 9.95 % | 10.0 |
| Industry Average | 10,871.90 Cr | 1,126.50 | 31.82 | 382.34 | 0.44% | 15.21% | 19.87% | 7.04 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.36 | 23.21 | 16.90 | 11.09 | 7.33 | 29.55 | 20.29 | 9.48 | 11.66 | 32.24 | 24.30 | 22.31 | 23.20 |
| Expenses | 5.87 | 19.56 | 14.18 | 11.92 | 9.19 | 24.27 | 17.25 | 9.87 | 13.18 | 26.89 | 20.91 | 20.49 | 22.47 |
| Operating Profit | -0.51 | 3.65 | 2.72 | -0.83 | -1.86 | 5.28 | 3.04 | -0.39 | -1.52 | 5.35 | 3.39 | 1.82 | 0.73 |
| OPM % | -9.51% | 15.73% | 16.09% | -7.48% | -25.38% | 17.87% | 14.98% | -4.11% | -13.04% | 16.59% | 13.95% | 8.16% | 3.15% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.02 | 0.00 | 0.01 | 0.06 | 0.00 |
| Interest | 0.39 | 0.41 | 0.44 | 0.47 | 0.48 | 0.46 | 0.46 | 0.47 | 0.44 | 0.37 | 0.45 | 0.74 | 0.48 |
| Depreciation | 0.29 | 0.30 | 0.30 | 0.31 | 0.36 | 0.41 | 0.40 | 0.41 | 0.42 | 0.43 | 0.44 | 0.45 | 0.43 |
| Profit before tax | -1.19 | 2.94 | 1.98 | -1.61 | -2.70 | 4.41 | 2.18 | -1.23 | -2.36 | 4.55 | 2.51 | 0.69 | -0.18 |
| Tax % | 62.18% | 28.91% | 28.79% | -32.92% | -24.81% | 27.66% | 32.11% | -27.64% | -24.15% | 30.33% | 29.08% | -7.25% | 16.67% |
| Net Profit | -1.94 | 2.10 | 1.41 | -1.08 | -2.03 | 3.19 | 1.48 | -0.90 | -1.78 | 3.17 | 1.77 | 0.74 | -0.21 |
| EPS in Rs | -3.72 | 4.03 | 2.71 | -2.07 | -3.90 | 6.12 | 2.84 | -1.73 | -3.42 | 6.08 | 3.40 | 1.42 | -0.40 |
Last Updated: August 19, 2025, 10:15 pm
Below is a detailed analysis of the quarterly data for Bhaskar Agrochemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 23.20 Cr.. The value appears strong and on an upward trend. It has increased from 22.31 Cr. (Mar 2025) to 23.20 Cr., marking an increase of 0.89 Cr..
- For Expenses, as of Jun 2025, the value is 22.47 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 20.49 Cr. (Mar 2025) to 22.47 Cr., marking an increase of 1.98 Cr..
- For Operating Profit, as of Jun 2025, the value is 0.73 Cr.. The value appears to be declining and may need further review. It has decreased from 1.82 Cr. (Mar 2025) to 0.73 Cr., marking a decrease of 1.09 Cr..
- For OPM %, as of Jun 2025, the value is 3.15%. The value appears to be declining and may need further review. It has decreased from 8.16% (Mar 2025) to 3.15%, marking a decrease of 5.01%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.06 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.06 Cr..
- For Interest, as of Jun 2025, the value is 0.48 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.74 Cr. (Mar 2025) to 0.48 Cr., marking a decrease of 0.26 Cr..
- For Depreciation, as of Jun 2025, the value is 0.43 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.45 Cr. (Mar 2025) to 0.43 Cr., marking a decrease of 0.02 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.18 Cr.. The value appears to be declining and may need further review. It has decreased from 0.69 Cr. (Mar 2025) to -0.18 Cr., marking a decrease of 0.87 Cr..
- For Tax %, as of Jun 2025, the value is 16.67%. The value appears to be increasing, which may not be favorable. It has increased from -7.25% (Mar 2025) to 16.67%, marking an increase of 23.92%.
- For Net Profit, as of Jun 2025, the value is -0.21 Cr.. The value appears to be declining and may need further review. It has decreased from 0.74 Cr. (Mar 2025) to -0.21 Cr., marking a decrease of 0.95 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.40. The value appears to be declining and may need further review. It has decreased from 1.42 (Mar 2025) to -0.40, marking a decrease of 1.82.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:04 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 27 | 26 | 28 | 28 | 52 | 52 | 52 | 64 | 62 | 55 | 67 | 91 | 110 |
| Expenses | 26 | 25 | 26 | 26 | 50 | 49 | 49 | 61 | 57 | 50 | 61 | 81 | 99 |
| Operating Profit | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 5 | 5 | 6 | 9 | 11 |
| OPM % | 5% | 5% | 7% | 8% | 4% | 6% | 6% | 5% | 8% | 9% | 9% | 10% | 10% |
| Other Income | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
| Depreciation | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Profit before tax | 1 | 1 | 2 | 1 | 0 | 1 | 1 | 1 | 2 | 2 | 3 | 5 | 7 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 44% | 88% | 34% | 28% | |
| Net Profit | 1 | 1 | 2 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 2 | 4 | 6 |
| EPS in Rs | 2.63 | 2.02 | 3.03 | 1.65 | 0.75 | 1.38 | 1.17 | 1.63 | 2.09 | 0.44 | 3.34 | 7.49 | 10.72 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 100.00% | -50.00% | -100.00% | 0.00% | 0.00% | 0.00% | -100.00% | 100.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 100.00% | -150.00% | -50.00% | 100.00% | 0.00% | 0.00% | -100.00% | 200.00% |
Bhaskar Agrochemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 12% |
| 3 Years: | 13% |
| TTM: | 44% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 45% |
| 3 Years: | 40% |
| TTM: | 175% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 55% |
| 3 Years: | 43% |
| 1 Year: | 70% |
| Return on Equity | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 13% |
| 3 Years: | 14% |
| Last Year: | 25% |
Last Updated: September 5, 2025, 2:41 pm
Balance Sheet
Last Updated: December 4, 2025, 2:32 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | -4 | -3 | -2 | 2 | 3 | 4 | 4 | 5 | 7 | 7 | 9 | 13 | 16 |
| Borrowings | 7 | 6 | 10 | 8 | 12 | 13 | 11 | 11 | 16 | 18 | 18 | 20 | 15 |
| Other Liabilities | 5 | 6 | 5 | 5 | 7 | 9 | 9 | 11 | 16 | 17 | 18 | 20 | 43 |
| Total Liabilities | 13 | 14 | 18 | 21 | 27 | 31 | 30 | 32 | 44 | 47 | 50 | 58 | 79 |
| Fixed Assets | 8 | 9 | 9 | 14 | 14 | 19 | 18 | 18 | 17 | 17 | 18 | 19 | 19 |
| CWIP | 0 | 0 | 4 | 1 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 5 | 5 | 6 | 6 | 9 | 12 | 11 | 13 | 27 | 30 | 31 | 40 | 59 |
| Total Assets | 13 | 14 | 18 | 21 | 27 | 31 | 30 | 32 | 44 | 47 | 50 | 58 | 79 |
Below is a detailed analysis of the balance sheet data for Bhaskar Agrochemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00 Cr..
- For Reserves, as of Sep 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2025) to 16.00 Cr., marking an increase of 3.00 Cr..
- For Borrowings, as of Sep 2025, the value is 15.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 20.00 Cr. (Mar 2025) to 15.00 Cr., marking a decrease of 5.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 43.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 20.00 Cr. (Mar 2025) to 43.00 Cr., marking an increase of 23.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 79.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 58.00 Cr. (Mar 2025) to 79.00 Cr., marking an increase of 21.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 19.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 19.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 59.00 Cr.. The value appears strong and on an upward trend. It has increased from 40.00 Cr. (Mar 2025) to 59.00 Cr., marking an increase of 19.00 Cr..
- For Total Assets, as of Sep 2025, the value is 79.00 Cr.. The value appears strong and on an upward trend. It has increased from 58.00 Cr. (Mar 2025) to 79.00 Cr., marking an increase of 21.00 Cr..
Notably, the Reserves (16.00 Cr.) exceed the Borrowings (15.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -6.00 | -5.00 | -8.00 | -6.00 | -10.00 | -10.00 | -8.00 | -8.00 | -11.00 | -13.00 | -12.00 | -11.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 3 | 7 | 10 | 7 | 8 | 20 | 38 | 20 | 76 | 111 | 82 | 86 |
| Inventory Days | 66 | 73 | 73 | 97 | 65 | 75 | 48 | 66 | 109 | 114 | 142 | 133 |
| Days Payable | 51 | 65 | 34 | 39 | 28 | 34 | 30 | 71 | 91 | 108 | 97 | 64 |
| Cash Conversion Cycle | 18 | 15 | 49 | 65 | 45 | 61 | 56 | 15 | 95 | 116 | 128 | 155 |
| Working Capital Days | -16 | -19 | -28 | -43 | -31 | -39 | -36 | -17 | 4 | 6 | 22 | 26 |
| ROCE % | 20% | 14% | 17% | 12% | 8% | 10% | 9% | 11% | 17% | 12% | 15% | 21% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 7.48 | 3.34 | 0.45 | 2.09 | 1.63 |
| Diluted EPS (Rs.) | 7.48 | 3.34 | 0.45 | 2.09 | 1.63 |
| Cash EPS (Rs.) | 10.82 | 6.40 | 2.77 | 4.26 | 3.60 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 34.07 | 26.58 | 23.22 | 22.71 | 19.69 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 34.07 | 26.58 | 23.22 | 22.71 | 19.69 |
| Revenue From Operations / Share (Rs.) | 173.73 | 128.21 | 106.30 | 125.72 | 122.77 |
| PBDIT / Share (Rs.) | 17.54 | 11.74 | 9.18 | 9.99 | 6.18 |
| PBIT / Share (Rs.) | 14.21 | 8.70 | 6.86 | 7.82 | 4.21 |
| PBT / Share (Rs.) | 10.37 | 5.10 | 3.57 | 3.74 | 1.63 |
| Net Profit / Share (Rs.) | 7.48 | 3.35 | 0.45 | 2.09 | 1.63 |
| PBDIT Margin (%) | 10.09 | 9.16 | 8.63 | 7.94 | 5.03 |
| PBIT Margin (%) | 8.17 | 6.78 | 6.44 | 6.22 | 3.43 |
| PBT Margin (%) | 5.96 | 3.98 | 3.36 | 2.97 | 1.33 |
| Net Profit Margin (%) | 4.30 | 2.61 | 0.42 | 1.66 | 1.33 |
| Return on Networth / Equity (%) | 21.95 | 12.60 | 1.94 | 9.21 | 8.29 |
| Return on Capital Employeed (%) | 29.23 | 19.67 | 18.20 | 23.01 | 14.20 |
| Return On Assets (%) | 6.67 | 3.48 | 0.49 | 2.47 | 2.69 |
| Long Term Debt / Equity (X) | 0.18 | 0.25 | 0.23 | 0.15 | 0.28 |
| Total Debt / Equity (X) | 1.07 | 1.09 | 1.29 | 1.12 | 0.74 |
| Asset Turnover Ratio (%) | 1.67 | 1.37 | 1.21 | 1.73 | 2.09 |
| Current Ratio (X) | 1.20 | 0.58 | 1.03 | 1.02 | 0.81 |
| Quick Ratio (X) | 0.65 | 0.58 | 0.61 | 0.51 | 0.24 |
| Inventory Turnover Ratio (X) | 0.00 | 7.97 | 3.24 | 4.73 | 7.71 |
| Interest Coverage Ratio (X) | 4.56 | 3.27 | 2.80 | 3.78 | 2.39 |
| Interest Coverage Ratio (Post Tax) (X) | 2.95 | 1.93 | 1.14 | 2.34 | 1.63 |
| Enterprise Value (Cr.) | 60.74 | 48.27 | 55.23 | 49.51 | 26.33 |
| EV / Net Operating Revenue (X) | 0.67 | 0.72 | 0.99 | 0.75 | 0.41 |
| EV / EBITDA (X) | 6.65 | 7.91 | 11.58 | 9.54 | 8.20 |
| MarketCap / Net Operating Revenue (X) | 0.44 | 0.46 | 0.67 | 0.50 | 0.26 |
| Price / BV (X) | 2.29 | 2.22 | 3.09 | 2.81 | 1.63 |
| Price / Net Operating Revenue (X) | 0.44 | 0.46 | 0.67 | 0.50 | 0.26 |
| EarningsYield | 0.09 | 0.05 | 0.01 | 0.03 | 0.05 |
After reviewing the key financial ratios for Bhaskar Agrochemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 7.48. This value is within the healthy range. It has increased from 3.34 (Mar 24) to 7.48, marking an increase of 4.14.
- For Diluted EPS (Rs.), as of Mar 25, the value is 7.48. This value is within the healthy range. It has increased from 3.34 (Mar 24) to 7.48, marking an increase of 4.14.
- For Cash EPS (Rs.), as of Mar 25, the value is 10.82. This value is within the healthy range. It has increased from 6.40 (Mar 24) to 10.82, marking an increase of 4.42.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 34.07. It has increased from 26.58 (Mar 24) to 34.07, marking an increase of 7.49.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 34.07. It has increased from 26.58 (Mar 24) to 34.07, marking an increase of 7.49.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 173.73. It has increased from 128.21 (Mar 24) to 173.73, marking an increase of 45.52.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 17.54. This value is within the healthy range. It has increased from 11.74 (Mar 24) to 17.54, marking an increase of 5.80.
- For PBIT / Share (Rs.), as of Mar 25, the value is 14.21. This value is within the healthy range. It has increased from 8.70 (Mar 24) to 14.21, marking an increase of 5.51.
- For PBT / Share (Rs.), as of Mar 25, the value is 10.37. This value is within the healthy range. It has increased from 5.10 (Mar 24) to 10.37, marking an increase of 5.27.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 7.48. This value is within the healthy range. It has increased from 3.35 (Mar 24) to 7.48, marking an increase of 4.13.
- For PBDIT Margin (%), as of Mar 25, the value is 10.09. This value is within the healthy range. It has increased from 9.16 (Mar 24) to 10.09, marking an increase of 0.93.
- For PBIT Margin (%), as of Mar 25, the value is 8.17. This value is below the healthy minimum of 10. It has increased from 6.78 (Mar 24) to 8.17, marking an increase of 1.39.
- For PBT Margin (%), as of Mar 25, the value is 5.96. This value is below the healthy minimum of 10. It has increased from 3.98 (Mar 24) to 5.96, marking an increase of 1.98.
- For Net Profit Margin (%), as of Mar 25, the value is 4.30. This value is below the healthy minimum of 5. It has increased from 2.61 (Mar 24) to 4.30, marking an increase of 1.69.
- For Return on Networth / Equity (%), as of Mar 25, the value is 21.95. This value is within the healthy range. It has increased from 12.60 (Mar 24) to 21.95, marking an increase of 9.35.
- For Return on Capital Employeed (%), as of Mar 25, the value is 29.23. This value is within the healthy range. It has increased from 19.67 (Mar 24) to 29.23, marking an increase of 9.56.
- For Return On Assets (%), as of Mar 25, the value is 6.67. This value is within the healthy range. It has increased from 3.48 (Mar 24) to 6.67, marking an increase of 3.19.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 0.2. It has decreased from 0.25 (Mar 24) to 0.18, marking a decrease of 0.07.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.07. This value exceeds the healthy maximum of 1. It has decreased from 1.09 (Mar 24) to 1.07, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.67. It has increased from 1.37 (Mar 24) to 1.67, marking an increase of 0.30.
- For Current Ratio (X), as of Mar 25, the value is 1.20. This value is below the healthy minimum of 1.5. It has increased from 0.58 (Mar 24) to 1.20, marking an increase of 0.62.
- For Quick Ratio (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 1. It has increased from 0.58 (Mar 24) to 0.65, marking an increase of 0.07.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. It has decreased from 7.97 (Mar 24) to 0.00, marking a decrease of 7.97.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 4.56. This value is within the healthy range. It has increased from 3.27 (Mar 24) to 4.56, marking an increase of 1.29.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.95. This value is below the healthy minimum of 3. It has increased from 1.93 (Mar 24) to 2.95, marking an increase of 1.02.
- For Enterprise Value (Cr.), as of Mar 25, the value is 60.74. It has increased from 48.27 (Mar 24) to 60.74, marking an increase of 12.47.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has decreased from 0.72 (Mar 24) to 0.67, marking a decrease of 0.05.
- For EV / EBITDA (X), as of Mar 25, the value is 6.65. This value is within the healthy range. It has decreased from 7.91 (Mar 24) to 6.65, marking a decrease of 1.26.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.46 (Mar 24) to 0.44, marking a decrease of 0.02.
- For Price / BV (X), as of Mar 25, the value is 2.29. This value is within the healthy range. It has increased from 2.22 (Mar 24) to 2.29, marking an increase of 0.07.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.46 (Mar 24) to 0.44, marking a decrease of 0.02.
- For EarningsYield, as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.09, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bhaskar Agrochemicals Ltd:
- Net Profit Margin: 4.3%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 29.23% (Industry Average ROCE: 15.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 21.95% (Industry Average ROE: 19.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.95
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.65
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 11.4 (Industry average Stock P/E: 31.82)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.07
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.3%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agro Chemicals/Pesticides | D. No.1-90/C, Office Unit-608,1T06, 6th Floor. Gowra Fountain Head, Hyderabad Telangana 500081 | bhaskaragro@yahoo.com http://www.bhaskaragro.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. P Pattabhi Rama Rao | Chairman & Managing Director |
| Mr. P Praveen Kumar | Joint Managing Director & CFO |
| Dr. Aluri Naga Uma Maheswara Prasad | Non Executive Director |
| Mrs. P Rajyalaxmi | Non Executive Director |
| Mr. S V Satyanarayana Chowdary | Independent Director |
| Mr. Sudhakar | Independent Director |
FAQ
What is the intrinsic value of Bhaskar Agrochemicals Ltd?
Bhaskar Agrochemicals Ltd's intrinsic value (as of 21 December 2025) is 91.91 which is 24.66% lower the current market price of 122.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 63.8 Cr. market cap, FY2025-2026 high/low of 149/56.6, reserves of ₹16 Cr, and liabilities of 79 Cr.
What is the Market Cap of Bhaskar Agrochemicals Ltd?
The Market Cap of Bhaskar Agrochemicals Ltd is 63.8 Cr..
What is the current Stock Price of Bhaskar Agrochemicals Ltd as on 21 December 2025?
The current stock price of Bhaskar Agrochemicals Ltd as on 21 December 2025 is 122.
What is the High / Low of Bhaskar Agrochemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Bhaskar Agrochemicals Ltd stocks is 149/56.6.
What is the Stock P/E of Bhaskar Agrochemicals Ltd?
The Stock P/E of Bhaskar Agrochemicals Ltd is 11.4.
What is the Book Value of Bhaskar Agrochemicals Ltd?
The Book Value of Bhaskar Agrochemicals Ltd is 40.0.
What is the Dividend Yield of Bhaskar Agrochemicals Ltd?
The Dividend Yield of Bhaskar Agrochemicals Ltd is 0.00 %.
What is the ROCE of Bhaskar Agrochemicals Ltd?
The ROCE of Bhaskar Agrochemicals Ltd is 21.3 %.
What is the ROE of Bhaskar Agrochemicals Ltd?
The ROE of Bhaskar Agrochemicals Ltd is 24.7 %.
What is the Face Value of Bhaskar Agrochemicals Ltd?
The Face Value of Bhaskar Agrochemicals Ltd is 10.0.